Healthy volunteers help test new heart attack drug
NCT ID NCT07079618
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This early-stage study tested a new drug called SGC001 in 49 healthy adults to see if it is safe and how the body processes it. The drug is being developed for future use in people who have had a heart attack. No treatment was given—this study only gathered safety information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Anzhen Hospital Capital Medical University
Beijing, Beijing Municipality, 100013, China
Conditions
Explore the condition pages connected to this study.